External-beam radiotherapy and/or HDR brachytherapy in postoperative endometrial cancer patients: Clinical outcomes and toxicity rates;Brachiterapia HDR associata o meno alla radioterapia a fasci esterni in pazienti operate per carcinoma endometriale: Risultati clinici e tossicità

Radiologia Medica

Volumn 118, Issue 2, 2013, Pages 311-322

  De Sanctis, V ^a   Agolli, L ^a   Valeriani, M ^a   Narici, S ^b   Osti, M F ^a   Patacchiola, F ^c   Mossa, B ^b   Moscarini, M ^b   Maurizi Enrici, R ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

Brachytherapy; Endometrial cancer; Radiotherapy

Indexed keywords

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER STAGING; COMPUTER ASSISTED RADIOTHERAPY; ENDOMETRIUM TUMOR; FEMALE; HUMAN; HYSTERECTOMY; LYMPH NODE METASTASIS; METASTASIS; METHODOLOGY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; OVARIECTOMY; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SALPINGECTOMY; SURVIVAL RATE; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYSTERECTOMY; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; OVARIECTOMY; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RETROSPECTIVE STUDIES; SALPINGECTOMY; SURVIVAL RATE; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 84877928689     PISSN: 00338362     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11547-012-0833-7     Document Type: Article

References (32)

1. Parkin DM, Bray F, Farley J, Pisani P (2005) Global Cancer Statistics, 2002. CA Cancer J Clin 55:74-108
2. Creasman WT, Odicino F, Maisonneuve P et al (2006) Carcinoma of the corpus uteri. FIGO 60th annual report on the results of treatment in gynecological cancer. Int J Gyneacol Obstet 95(Suppl 1):S105-S143
3. ACOG Committee on Practice Bulletins. American College of Obstetricians and Gynecologist (2005) ACOG practice bulletin, clinical management guidelines for obstetrician-gynecologist, n. 65 August 2005: management of endometrial cancer. Obstet Gynecol 106:413-425
4. Miller DA, Richardson S, Grigsby PW (2010) A new method of anatomically conformal vaginal cuff HDR brachytherapy. Gynecol Oncol 116:413-418
5. Alektiar KM, McKee A, Venkatraman E et al (2002) Intravaginal high-doserate brachytherapy for stage IB (FIGO Grade 1, 2) endometrial cancer. Int J Radiat Oncol Biol Phys 53:707-713
6. Rittenberg PV, Lotocki RJ, Heywood MS et al (2003) High-risk surgical stage 1 endometrial cancer: outcomes with vault brachytherapy alone. Gynecol Oncol 89:288-294
7. Jolly S, Vargas C, Kumar T et al (2005) Vaginal brachytherapy alone: An alternative to adjuvant whole pelvis radiation for early stage endometrial cancer. Gynecol Oncol 97:887-892
8. Gadducci A, Greco C (2010) The evolving role of adjuvant therapy in endometrial cancer. Crit Rev Oncol Hematol 78:79-91
9. Nout RA, Smit VT, Putter H et al (2010) Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial. Lancet 375:816-823
10. Nout RA, Putter H, Jürgenliemk-Schulz IM et al (2009) Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: first results of the randomized PORTEC-2 trial. J Clin Oncol 27:3547-3556
11. Kitchener H, Powell M (2010) Radiotherapy for endometrial cancer: a key in the jigsaw. Lancet 375:781-782
12. Cox JD, Stetz J, Pajak TF et al (1995) Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31:1341-1346
13. LENT-Soma tables (1995) Radiother Oncol 35:17-60
14. Crosby MA, Tward JD, Szabo A et al (2010) Does brachytherapy improve survival in addition to external beam radiation therapy in patients with high risk stage I and II endometrial carcinoma. American J of Clin Oncol 33:364-369
15. Scholtem AN, van Putten WL, Beerman H et al; PORTEC Study Group (2005) Postoperative radiotherapy for Stage 1 endometrial carcinoma: long-term outcome of the randomized PORTEC trial with central pathology review. Int J Radiat Oncol Biol Phys 6:834-838
16. Aalders J, Abeler V, Kolstad P, Onsrud M (1980) Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients. Obstet Gynecol 56:419-427
17. Keys HM, Roberts JA, Brunetto VL et al; Gynecologic Oncology Group (2004) A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 92:744-751
18. Creutzberg CL (2004) GOG-99: ending the controversy regarding pelvic radiotherapy for endometrial carcinoma? Gynecol Oncol 92:740-743
19. Viani GA, Patia BF, Pellizzon AC et al (2006) High-risk surgical stage I endometrial cancer: analysis of treatment out come. Radiat Oncol 1:24
20. Kitchener H, Swart AM, Qian Q et al; ASTEC study group (2009) Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet 373:125-136
21. Blake P, Swart AM, Orton J et al ASTEC Study Group (2009) Adjuvant external beam radiotherapy in the treatment of endometrial cancer: pooled trial results, systematic review, and metastatic-analysis. Lancet 373:37-46
22. Mariani A, Dowdy SC, Cliby WA et al (2006) Efficacy of systematic lymphadenctomy and adjuvant radiotherapy in node-positive endometrial cancer patients. Gynecol Oncol 101:200-208
23. Benedetti Panici P, Basile S, Maneschi F et al (2008) Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Nalt Cancer Inst 100:1707-1716
24. Rossi PJ, Jani AB, Horowitz IR, Johnstone PA (2008) Adjuvant brachytherapy removes survival disadvantage of local disease extension in stage IIIC endometrial cancer: a seer registry analysis. Int J rad Oncol Biol Phys 70:134-138
25. Korcum AF, Duman E, Aksu G (2010) The results of adjuvant radiotherapy in endometrial carcinoma. Gynecol Endocrinol 26:240-245
26. Cannon GM, Geye H, Terakedis BE et al (2009) Outcomes following surgery and adjuvant radiation in stage II endometrial adenocarcinoma. Gynec Oncol 113:176-180
27. Lin LL, Mutch DG, Rader JS et al (2007) External radiotherapy versus vaginal brachytherapy for patients with intermediate risk endometrial cancer. Gynec Oncol 106:215-220
28. Bolukbasi Y, Demirci S, Ozsaran Z et al (2008) Postoperative radiotherapy in intermediate and high-risk stage I endometrial cancer: analysis of prognostic factors and survival. Eur J Gynaecol Oncol 29:505-510
29. Maggi R, Lissoni A, Spina F et al (2006) Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomized trial. Br J Cancer 95:266-271
30. Huscher A, Bignardi M, Magri E et al (2009) Determinanats of small bowel toxicity in postoperative pelvic irradiation for gynaecological malignancies. Anticancer Res 9:4821-4826
31. Rovirosa A, Ascaso C, Sanchez-Reyes A et al (2010) Three or four fractions of 4-5 Gy per week in postoperative high-dose-rate brachytherapy for endometrial carcinoma. Int J Radiat Oncol Biol Phys 81:418-423
32. Klopp AH, Jhingran A, Ramondetta L et al (2009) Node-positive adenocarcinoma of the endometrium: outcome and patterns of recurrence with or without external beam irradiation. Gynecol Oncol 115:6-11